These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9395501)

  • 21. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation.
    Azriel R; Gazit E
    J Biol Chem; 2001 Sep; 276(36):34156-61. PubMed ID: 11445568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly.
    Liao MC; Hoos MD; Aucoin D; Ahmed M; Davis J; Smith SO; Van Nostrand WE
    J Biol Chem; 2010 Nov; 285(46):35590-8. PubMed ID: 20807757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
    Yan LM; Velkova A; Kapurniotu A
    Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid peptide channels: blockade by zinc and inhibition by Congo red (amyloid channel block).
    Hirakura Y; Yiu WW; Yamamoto A; Kagan BL
    Amyloid; 2000 Sep; 7(3):194-9. PubMed ID: 11019860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
    Kisilevsky R; Szarek WA
    J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-amyloidogenic property of human gastrokine 1.
    Altieri F; Di Stadio CS; Severino V; Sandomenico A; Minopoli G; Miselli G; Di Maro A; Ruvo M; Chambery A; Quagliariello V; Masullo M; Rippa E; Arcari P
    Biochimie; 2014 Nov; 106():91-100. PubMed ID: 25139219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the Alzheimer's disease-associated CLAC protein and identification of an amyloid beta-peptide-binding site.
    Söderberg L; Kakuyama H; Möller A; Ito A; Winblad B; Tjernberg LO; Näslund J
    J Biol Chem; 2005 Jan; 280(2):1007-15. PubMed ID: 15522881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid Fibrils.
    Stewart KL; Hughes E; Yates EA; Middleton DA; Radford SE
    J Mol Biol; 2017 Aug; 429(16):2449-2462. PubMed ID: 28697887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
    Singh PK; Maji SK
    Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25-35.
    Syad AN; Devi KP
    Neurol Res; 2015 Jan; 37(1):14-22. PubMed ID: 25016970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant.
    Muñoz FJ; Opazo C; Gil-Gómez G; Tapia G; Fernández V; Valverde MA; Inestrosa NC
    J Neurosci; 2002 Apr; 22(8):3081-9. PubMed ID: 11943811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of Abeta fibril formation.
    Wood SJ; MacKenzie L; Maleeff B; Hurle MR; Wetzel R
    J Biol Chem; 1996 Feb; 271(8):4086-92. PubMed ID: 8626745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient small molecule interactions kinetically modulate amyloid β peptide self-assembly.
    Abelein A; Lang L; Lendel C; Gräslund A; Danielsson J
    FEBS Lett; 2012 Nov; 586(22):3991-5. PubMed ID: 23058290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
    Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.
    Hughes E; Burke RM; Doig AJ
    J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.
    Gordon LM; Nisthal A; Lee AB; Eskandari S; Ruchala P; Jung CL; Waring AJ; Mobley PW
    Biochim Biophys Acta; 2008 Oct; 1778(10):2127-37. PubMed ID: 18515070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.